RESTART C0168Z05 Rheumatoid Arthritis Study (Q64718924)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RESTART C0168Z05 Rheumatoid Arthritis Study |
clinical trial |
Statements
A Phase 4, Multicenter, Open-Label, Assessor-Blinded Switch Study of the Efficacy and Safety of Infliximab (REMICADE) in Patients With Active Rheumatoid Arthritis Who Are Responding Inadequately to Etanercept (ENBREL) or Adalimumab (HUMIRA). (English)
0 references
July 2008
0 references
January 2010
0 references
203
0 references
18 year
0 references